Utah Medical Products, Inc. Form 8-K January 23, 2007

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934



Date of Report (date of earliest event reported): January 23, 2007


Commission File No. 0-11178


UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)


UTAH
87-0342734
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)


7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices


Registrant's telephone number:    (801) 566-1200







 
 
 


ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 
Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the quarter and year ended December 31, 2006 and forward-looking statements relating to 2007 and beyond as presented in a press release dated January 23, 2007. The information in this report shall be deemed incorporated by reference into any registration statement heretofore or hereafter filed under the Securities Act of 1933, as amended, except to the extent that such information is superseded by information as of a subsequent date that is included in or incorporated by reference into such registration statement. The information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended.


 
SIGNATURES

 
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
UTAH MEDICAL PRODUCTS, INC.
 
REGISTRANT
     
     
Date:      1/23/2007     
By:
    /s/ Kevin L. Cornwell
   
Kevin L. Cornwell
   
CEO




 
EXHIBIT INDEX

Index
Number
Description

99.1
Financial information for Utah Medical Products, Inc. for the quarter and year ended December 31, 2006 and forward-looking statements relating to 2007 and beyond as presented in a press release dated January 23, 2007.